Furthermore, DNMTs are increased in WAT in patients with obesity, thereby inducing the methylation rate of the promoter region of the Krüppel-like factor 4 (KLF4) gene (an anti-inflammatory factor) and suppressing this expression [86]. The gene discussed is KLF4; the disease is Obesity.